Literature DB >> 31385170

Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus Eradication.

Hiroji Shinkawa1, Shogo Tanaka2, Shigekazu Takemura2, Tokuji Ito2, Takanori Aota2, Toru Miyazaki2, Shoji Kubo2.   

Abstract

PURPOSE: This study aimed to evaluate survival outcomes in patients with non-B non-C hepatocellular carcinoma (NBNC-HCC) with reference to patients with HCC achieving sustained virological response (SVR) by preoperative interferon (IFN) treatment for chronic hepatitis C.
METHODS: We examined 781 patients who underwent hepatic resection for HCC. They were classified into NBNC-HCC, SVR-HCC, and non-SVR HCC groups.
RESULTS: Multivariate analysis for recurrence-free survival (RFS) and overall survival (OS) revealed that the adjusted hazard ratios (HR) of NBNC-HCC and non-SVR HCC groups with reference to the SVR-HCC group were 1.46 (p = 0.10) and 2.10 (p < 0.001), respectively, for RFS, and 1.69 (p = 0.024) and 2.11 (p < 0.001), respectively, for OS. Worsening of Child-Pugh grade at recurrence was confirmed in 21 patients (17.1%) with NBNC-HCC but not in those with SVR-HCC (p = 0.017, SVR vs. NBNC). In the NBNC-HCC group, hepatic resection for intrahepatic recurrence was adopted in 17.4% of patients without worsening of Child-Pugh grade at recurrence, whereas hepatic resection was not adopted in those with grade worsening. Among patients with alcoholic hepatitis, Child-Pugh grade worsening at recurrence was more frequently observed in patients with sobriety than those without sobriety (14.3% vs. 46.2%, p = 0.049).
CONCLUSIONS: NBNC-HCC patients had an increased risk for overall death as compared with those with SVR-HCC. Worsening of background liver function may reduce the chances of re-hepatic resection for recurrence and increase the risk for overall death in NBNC-HCC patients. For alcoholic hepatitis patients, sobriety may prevent deterioration of liver function after surgery.

Entities:  

Keywords:  Non-B non-C hepatocellular carcinoma; Overall survival; Sustained virological response

Mesh:

Substances:

Year:  2019        PMID: 31385170     DOI: 10.1007/s11605-019-04339-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  2 in total

1.  Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.

Authors:  Kazuhisa Kaneda; Shoji Kubo; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Shintaro Kodai; Hiroji Shinkawa; Yorihisa Urata; Masayuki Sakae; Takatsugu Yamamoto; Shigefumi Suehiro
Journal:  Hepatogastroenterology       Date:  2012-09

Review 2.  Prognostic Factors and Staging Systems in Hepatocellular Carcinoma.

Authors:  Haldun Selçuk
Journal:  Exp Clin Transplant       Date:  2017-03       Impact factor: 0.945

  2 in total
  2 in total

1.  Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease.

Authors:  Daisuke Shirai; Hiroji Shinkawa; Shigekazu Takemura; Shogo Tanaka; Ryosuke Amano; Kenjiro Kimura; Masahiko Kinoshita; Norifumi Kawada; Shoji Kubo
Journal:  Ann Med Surg (Lond)       Date:  2021-07-29

2.  Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study.

Authors:  Ryo Saito; Hidetake Amemiya; Naohiro Hosomura; Hiromichi Kawaida; Katsutoshi Shoda; Shinji Furuya; Hidenori Akaike; Yoshihiko Kawaguchi; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Surg Oncol       Date:  2022-03-22       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.